BALL BRYAN 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
BALL BRYAN
Chief Quality Officer
Transactions
- Award
Option to Purchase Common Stock
2021-01-11+39,185→ 39,185 totalExercise: $31.26Exp: 2031-01-11→ Common Stock (39,185 underlying) - Award
Common Stock
2021-01-11+25,000→ 25,000 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and the remaining shares vesting pro rata on each subsequent three-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date is January 11, 2021.
- [F2]The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 11, 2021.